Five-year surveillance of antimicrobial use in Chinese Pediatric Intensive Care Units

Journal of Tropical Pediatrics

Volumn 54, Issue 4, 2008, Pages 238-242

  Ding, Hui ^a   Yang, Yonghong ^a   Lu, Quan ^b   Wang, Yi ^c   Chen, Yuan ^d   Deng, Li ^e   Wang, Aihua ^a   Deng, Qiulian ^e   Zhang, Hong ^b   Wang, Chuanqing ^c   Liu, Lan ^d   Xu, Xiwei ^a   Wang, Li ^a   Shen, Xuzhuang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d CHONGQING MEDICAL UNIVERSITY   (China)

^e Guangzhou Children's Hospital   (China)

Author keywords

Antimicrobial use; China; Pediatric intensive care units (PICUs)

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFACLOR; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; ERYTHROMYCIN; MACROLIDE; MEROPENEM; PENICILLIN DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT;

ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CHILD; CHINA; DIARRHEA; DRUG COST; DRUG INTOXICATION; DRUG USE; FEMALE; HOSPITALIZATION; HUMAN; INFANT; INTENSIVE CARE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PEDIATRIC HOSPITAL; PNEUMONIA; RESPIRATORY TRACT INFECTION; WORLD HEALTH ORGANIZATION;

ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; CHINA; HOSPITALS, TEACHING; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; LENGTH OF STAY; MULTICENTER STUDIES AS TOPIC; POPULATION SURVEILLANCE;

EID: 48549103404     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmm118     Document Type: Article

References (24)

1. Foglia EE, Fraser VJ, Elward AM. Effect of nosocomial infections due to antibiotic-resistant organisms on length of stay and mortality in the pediatric intensive care unit. Infect Control Hosp Epidemiol 2007;28: 299-306.
2. Alberti C, Brun-Buisson C, Burchardi H, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intens Care Med 2002;28:108-21.
3. Resi D, Milandri M, Moro ML, et al. Antibiotic prescriptions in children. J Antimicrob Chemother 2003;52:282-6.
4. Katragkou A, Kotsiou M, Antachopoulos C. Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: A case-control study. Intens Care Med 2006;32:1384-91.3
5. Kollef MH. Is there a role for antibiotic cycling in the intensive care unit? Crit Care Med 2001;29(4Suppl): N135-42.
6. Niederman MS. Impact of antibiotic resistance on clinical outcomes and the cost of care. Crit Care Med 2001;29(Suppl 4): S114-20.
7. Armenian SH, Singh J, Arrietal AC, et al. Risk factors for mortality resulting from bloodstream infections in a pediatric intensive care unit. Pediatr Infect Dis J 2005;24:309-14.
8. Hoffken G, Niederman MS. Nosocomial pneumonia: The importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest 2002;122: 2183-96.
9. World Health Organization Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) Classification System: Guidelines for ATC Classification and DDD Assignment. Available at: http://www.whocc.no/atcddd/.2007
10. Filius PMG, Liem TBY, van der Linden PD, et al. An additional measure for quantifying antibiotic use in hospitals. J Antimicrob Chemother 2005;55:805-8.
11. Liem TBY, Filius PMG, van der Linden PD, et al. Changes in antibiotic use in Dutch hospitals over a sixyear period: 1997 to 2002. Neth J Med 2005;63:354-60.
12. Rello J, Sa-Borges M, Correa H, et al. Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999;160:608-13.
13. Thuong M, Shortgen F, Zazempa V, et al. Appropriate use of restricted antimicrobial agents in hospitals: The importance of empirical therapy and assisted re-evaluation. J Antimicrob Chemother 2000;46: 501-8.
14. Melander E, Nissen A, Henricson K, et al. Utilisation of antibiotics in young children: Opposite relationships to adult educational levels in Danish and Swedish counties. Eur J Clin Pharmacol 2003;59:331-5.
15. Vaccheri A, Bjerrum L, Resi D, et al. Antibiotic prescribing in general practice: Striking differences between Italy (Ravenna) and Denmark (Funen). J Antimicrob Chemother 2002;50:989-97.
16. Palcevski G, Ahel V, Vlahovic-Palcevski V, et al. Antibiotic use profile at paediatric clinics in two transitional countries. Pharmacoepidemiol Drug Saf 2004;13:181-5.
17. Ministry of Public Health. Guidelines to Use of Antibiotics in Clinic (in Chinese). Natl Med J China 2004;84:2026-56.
18. Kolar M, Urbanek K, Latal T. Antibiotic selective pressure and development of bacterial resistance. Int J Antimicrob Agents 2001;17:357-63.
19. Rice LB, Willey SH, Papanicolaou GA, et al. Outbreak of ceftazidime resistance caused by extended-spectrum b-lactamases at a Massachusetts chronic care facility. Antimicrob Agents Chemother 1990;34:2193-9.
20. Rahal JJ, Urban C, Horn D, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. J Am Med Assoc 1998;280:1233-7.
21. Lisa A, Grohskopf W, Huskins C, et al. Use of Antimicrobial Agents in United States Neonatal and Pediatric Intensive Care Patients. Pediatr Infect Dis J 2005;24:766-73.
22. Raymond DP, Pelletier SJ, Crabtree TD, et al. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit Care Med 2001;29:1101-8.
23. Erbay A, Bodur H, Akinci E, et al. Evaluation of antibiotic use in intensive care units of a tertiary care hospital in Turkey. J Hosp Infect 2005;59:53-61.
24. Allegranzi B, Luzzati R, Luzzani A, et al. Impact of antibiotic changes in empirical therapy on antimicrobial resistance in intensive care unit-acquired infections. J Hosp Infect 2002;52:136-40.